The birth of a new radiopharmaceutical. Industrial perspective: from IND to NDA

J Nucl Cardiol. 1995 Jan-Feb;2(1):66-70. doi: 10.1016/s1071-3581(05)80010-8.
No abstract available

MeSH terms

  • Drug Industry*
  • Heart / diagnostic imaging*
  • Humans
  • Radionuclide Imaging
  • Radiopharmaceuticals*
  • United States
  • United States Food and Drug Administration*

Substances

  • Radiopharmaceuticals